Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 5/20 | 0.33 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL289402 | 0.81 | CYP1A2 (0.31) | CYP1A2HRH2HRH1HRH4 | |
| SCHEMBL13802271 | 0.79 | — | — | |
| SCHEMBL6127283 | 0.79 | TP53 (0.32) | TP53THRB | |
| SCHEMBL8480291 | 0.79 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL2489354 | 0.79 | HRH2 (0.55) | ALDH1A1GAACYP1A2HRH2HRH1 | |
| SCHEMBL4565613 | 0.76 | KMT2A (0.43) | ALDH1A1 | |
| SCHEMBL6120940 | 0.76 | LMNA (0.34) | — | |
| SCHEMBL5162056 | 0.76 | FBP1 (0.33) | — | |
| SCHEMBL6157704 | 0.76 | ITGB3 (0.34) | ALDH1A1 | |
| SCHEMBL25398658 | 0.75 | SLC6A3 (0.35) | SLC6A3ALDH1A1GAATP53THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2935256-A1 | 4,6-DIARYLAMINOTHIAZINES AS BACE1 INHIBITORS AND THEIR USE FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | Bristol-Myers Squibb Company (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014098831-A1 | 4,6-DIARYLAMINOTHIAZINES AS BACE1 INHIBITORS AND THEIR USE FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-2726073-A1 | METHODS OF TREATMENT USING ALLOSTERIC PROCESSING INHIBITORS FOR MATRIX METALLOPROTEINASES | Janssen Pharmaceutica, N.V. (BE) | 2014-05-07 | — | — | EP | disclosed |
| EP-2727032-A2 | METHODS FOR DESIGNING, SELECTING AND/OR OPTIMIZING ALLOSTERIC PROCESSING INHIBITORS FOR MATRIX METALLOPROTEINASES | Janssen Pharmaceutica, N.V. (BE) | 2014-05-07 | — | — | EP | disclosed |
| EP-2727038-A1 | CRYSTAL STRUCTURE OF THE PRO FORM OF A MATRIX METALLOPROTEINASE AND AN ALLOSTERIC PROCESSING INHIBITOR | Janssen Pharmaceutica N.V. (BE) | 2014-05-07 | — | — | EP | disclosed |
| EP-2366704-B1 | Inhibitors of serine proteases | VERTEX PHARMA (US) | 2013-10-23 | — | — | EP | disclosed |
| WO-2013003360-A1 | METHODS OF TREATMENT USING ALLOSTERIC PROCESSING INHIBITORS FOR MATRIX METALLOPROTEINASES | JANSSEN PHARMACEUTICA NV (BE) | 2013-01-03 | — | — | WO | disclosed |
| WO-2013003352-A1 | CRYSTAL STRUCTURE OF THE PRO FORM OF A MATRIX METALLOPROTEINASE AND AN ALLOSTERIC PROCESSING INHIBITOR | JANSSEN PHARMACEUTICA NV (BE) | 2013-01-03 | — | — | WO | disclosed |
| WO-2013003358-A2 | METHODS FOR DESIGNING, SELECTING AND/OR OPTIMIZING ALLOSTERIC PROCESSING INHIBITORS FOR MATRIX METALLOPROTEINASES | JANSSEN PHARMACEUTICA NV (BE) | 2013-01-03 | — | — | WO | disclosed |
| WO-2012162468-A1 | THIAZOL DERIVATIVES AS PRO -MATRIX METALLOPROTEINASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2012-11-29 | — | — | WO | disclosed |
| WO-2012068209-A2 | BISTHIAZOLE INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION | JANSSEN PHARMACEUTICA NV (BE) | 2012-05-24 | — | — | WO | disclosed |
| EP-2114867-A1 | AMINOAMIDES AS OREXIN ANTAGONISTS | F. Hoffmann-Roche AG (CH) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008107335-A1 | AMINOAMIDES AS OREXIN ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-09-12 | — | — | WO | disclosed |
| EP-1735319-A1 | INHIBITORS OF HISTONE DEACETYLASE | Methylgene, Inc. (CA) | 2006-12-27 | — | — | EP | disclosed |
| WO-2005092899-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2005-10-06 | — | — | WO | disclosed |
| EP-1581231-A1 | ANTI-VIRAL COMPOUNDS | Cyclacel Limited (GB) | 2005-10-05 | — | — | EP | disclosed |
| EP-1430051-A1 | N-(4-(4-METHYLTHIAZOL-5-YL)PYRIMIDIN-2-YL)-N-PHENYLAMINES AS ANTIPROLIFERATIVE COMPOUNDS | Cyclacel Limited (GB) | 2004-06-23 | — | — | EP | disclosed |
| WO-2004043467-A1 | ANTI-VIRAL COMPOUNDS | CYCLACEL LIMITED (GB) | 2004-05-27 | — | — | WO | disclosed |
| WO-2003029248-A1 | N-(4-(4-METHYLTHIAZOL-5-YL) PYRIMIDIN-2-YL) -N-PHENYLAMINES AS ANTIPROLIFERATIVE COMPOUNDS | CYCLACEL LIMITED (GB) | 2003-04-10 | — | — | WO | disclosed |